T1	Condition 11 34	ischaemic heart disease
T2	Condition 36 51	cardiac failure
T3	Condition 53 76	cerebrovascular disease
T4	Condition 78 94	liver impairment
T5	Measurement 96 99	ALT
T6	Measurement 100 103	AST
*	OR T6 T5
T7	Value 103 110	>50IU/L
R1	Has_value Arg1:T6 Arg2:T7	
R2	Has_value Arg1:T5 Arg2:T7	
T8	Measurement 115 120	stage
T9	Value 121 124	3-5
R3	Has_value Arg1:T8 Arg2:T9	
T10	Condition 125 147	chronic kidney disease
R4	AND Arg1:T10 Arg2:T8	
T11	Scope 96 110	ALT/AST>50IU/L
R5	Subsumes Arg1:T4 Arg2:T11	
*	OR T1 T2 T3 T4 T8
T12	Condition 161 169	overdose
T13	Condition 173 190	suicidal ideation
*	OR T13 T12
T14	Measurement 201 209	weighing
T15	Value 210 216	<55kgs
R6	Has_value Arg1:T14 Arg2:T15	
T16	Condition 233 245	chronic pain
T17	Qualifier 246 265	requiring treatment
R7	Has_qualifier Arg1:T16 Arg2:T17	
T18	Condition 274 287	known allergy
T19	Drug 291 302	paracetamol
R8	AND Arg1:T18 Arg2:T19	
T20	Drug 326 359	non-steroidal anti-inflammatories
T21	Temporal 307 318	concomitant
T22	Drug 362 381	oral anticoagulants
T23	Drug 385 400	corticosteroids
*	OR T23 T22 T20
T24	Scope 326 400	non-steroidal anti-inflammatories , oral anticoagulants or corticosteroids
R9	Has_temporal Arg1:T24 Arg2:T21	
*	OR T18 T24
